Top compounds associated with response to RFNG


Feature Type Standardized
Nominal ANOVA
mRNA SN-38 GDSC1000 pan-cancer AAC 0.08 0.02
mRNA SNX-2112 CTRPv2 pan-cancer AAC -0.077 0.02
mRNA navitoclax:gemcitabine (1:1 mol/mol) CTRPv2 pan-cancer AAC -0.081 0.02
mRNA thapsigargin GDSC1000 pan-cancer AAC 0.082 0.02
mRNA tivozanib CTRPv2 pan-cancer AAC 0.086 0.02
mRNA shikonin GDSC1000 pan-cancer AAC 0.08 0.02
mRNA NPK76-II-72-1 GDSC1000 pan-cancer AAC -0.068 0.02
mRNA Rapamycin CTRPv2 pan-cancer AAC -0.08 0.02
mRNA tanespimycin:bortezomib (250:1 mol/mol) CTRPv2 pan-cancer AAC -0.085 0.02
mRNA RO-3306 GDSC1000 pan-cancer AAC 0.079 0.02
Download CSV